ArticleCancer research communications2025

Preclinical Evaluation of Folate Receptor-α Chimeric Antigen Receptor T Cells Exhibits Highly Efficient Antitumor Activity against Osteosarcoma.

Michelle Choe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.